Calabresi, Paolo
 Distribuzione geografica
Continente #
AS - Asia 6.755
NA - Nord America 5.554
EU - Europa 4.894
SA - Sud America 2.114
AF - Africa 241
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 6
Totale 19.591
Nazione #
US - Stati Uniti d'America 5.295
SG - Singapore 3.484
BR - Brasile 1.800
CN - Cina 1.382
IT - Italia 1.226
SE - Svezia 798
DE - Germania 751
VN - Vietnam 457
IE - Irlanda 389
FR - Francia 347
FI - Finlandia 291
ID - Indonesia 286
HK - Hong Kong 270
GB - Regno Unito 256
RU - Federazione Russa 200
IN - India 186
AR - Argentina 124
PL - Polonia 118
NL - Olanda 117
CA - Canada 112
KR - Corea 102
BD - Bangladesh 98
IQ - Iraq 97
MX - Messico 92
ZA - Sudafrica 83
AT - Austria 72
UA - Ucraina 69
JP - Giappone 64
ES - Italia 58
TR - Turchia 56
EC - Ecuador 50
CI - Costa d'Avorio 37
VE - Venezuela 37
MA - Marocco 35
CZ - Repubblica Ceca 33
PK - Pakistan 33
IR - Iran 29
SA - Arabia Saudita 28
BE - Belgio 26
CH - Svizzera 26
CO - Colombia 26
LT - Lituania 25
KE - Kenya 24
PY - Paraguay 21
CL - Cile 19
UZ - Uzbekistan 18
JO - Giordania 17
AE - Emirati Arabi Uniti 16
IL - Israele 15
PH - Filippine 14
UY - Uruguay 14
AZ - Azerbaigian 13
EG - Egitto 13
AU - Australia 12
BO - Bolivia 12
GR - Grecia 12
KZ - Kazakistan 12
JM - Giamaica 11
LB - Libano 11
NZ - Nuova Zelanda 11
TN - Tunisia 11
NP - Nepal 10
PA - Panama 9
PT - Portogallo 9
CR - Costa Rica 8
DZ - Algeria 8
PE - Perù 8
PS - Palestinian Territory 8
AL - Albania 7
BY - Bielorussia 7
DK - Danimarca 6
DO - Repubblica Dominicana 6
HN - Honduras 6
NG - Nigeria 6
QA - Qatar 6
RS - Serbia 6
SN - Senegal 6
BG - Bulgaria 5
HU - Ungheria 5
MK - Macedonia 5
OM - Oman 5
RO - Romania 5
TW - Taiwan 5
KG - Kirghizistan 4
MY - Malesia 4
NO - Norvegia 4
SI - Slovenia 4
SY - Repubblica araba siriana 4
AM - Armenia 3
GA - Gabon 3
GT - Guatemala 3
LU - Lussemburgo 3
NI - Nicaragua 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
TV - Tuvalu 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
BF - Burkina Faso 2
Totale 19.540
Città #
Singapore 1.496
Ashburn 779
Chandler 491
Dublin 384
Munich 381
Beijing 374
Hefei 307
Jakarta 261
Rome 258
Los Angeles 229
New York 227
Helsinki 171
Milan 171
Princeton 161
Ho Chi Minh City 153
Hong Kong 151
São Paulo 143
Chicago 139
Moscow 138
Boston 130
Wilmington 123
San Mateo 119
Dallas 118
Frankfurt am Main 116
Hanoi 116
The Dalles 116
Seoul 100
Warsaw 95
Kent 91
Nuremberg 74
Boardman 63
Rio de Janeiro 56
Turku 56
North Bergen 54
Fairfield 53
Brooklyn 52
Buffalo 51
Johannesburg 50
Tokyo 50
Houston 48
Santa Clara 48
Ann Arbor 45
Lappeenranta 45
Montreal 45
Redwood City 45
Denver 44
London 43
Washington 41
Busto Arsizio 39
Baghdad 38
Abidjan 37
Seattle 36
Chennai 35
Vienna 35
Atlanta 34
Orem 34
Phoenix 34
Belo Horizonte 31
Brasília 31
Falkenstein 31
Mexico City 31
Norwalk 31
Stockholm 31
Düsseldorf 30
Marseille 29
Brno 28
Curitiba 28
Amsterdam 27
Portsmouth 27
Porto Alegre 26
Toronto 26
Bremen 25
Woodbridge 25
Brussels 24
Poplar 24
Paris 23
Bexley 21
Campinas 21
Cattolica 20
Jacksonville 20
Quito 20
Casalecchio di Reno 19
Lauterbourg 19
Nairobi 19
Salt Lake City 19
San Jose 19
Ribeirão Preto 18
San Francisco 18
Amman 17
Cambridge 16
Da Nang 16
Dhaka 16
Guangzhou 16
Mountain View 16
Tashkent 16
Trieste 16
Ankara 15
Buenos Aires 15
Haiphong 15
Hyderabad 15
Totale 9.773
Nome #
A microbially produced AhR ligand promotes a Tph1-driven tolerogenic program in multiple sclerosis 294
Optical Coherence Tomography Advanced Parameters in Patients With Multiple Sclerosis: Ophthalmological and Neurological Assessments 226
Hospital admissions from the emergency department of adult patients affected by myopathies 220
Heart Rate Variability during wake and sleep in Huntington's Disease patients. An observational, cross-sectional, cohort study 220
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 199
Personalized Clinical Phenotyping through Systems Medicine and Artificial Intelligence 190
Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington's disease 187
Assessment of neurological manifestations in hospitalized patients with COVID-19 172
A real-time integrated framework to support clinical decision making for covid-19 patients 159
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 148
Host and Microbial Tryptophan Metabolic Profiling in Multiple Sclerosis 143
Effects of COVID-19 Lockdown on Movement Disorders Patients With Deep Brain Stimulation: A Multicenter Survey 142
Extradural Motor Cortex Stimulation in Parkinson's Disease: Long-Term Clinical Outcome. 136
Role of Favorable Perfusion Imaging in Predicting the Outcome of Patients with Acute Ischemic Stroke due to Large Vessel Occlusion Undergoing Effective Thrombectomy: A Single-Center Study 134
Extradural Motor Cortex Stimulation might improve episodic and working memory in patients with Parkinson’s disease 131
COVID-19 and stroke: From the cases to the causes 129
Effect of lockdown on the management of ischemic stroke: an Italian experience from a COVID hospital 124
Effect of the COVID-19 pandemic and the lockdown measures on the local stroke network 120
Gastrointestinal Manifestations in Hereditary Transthyretin Amyloidosis: a Single-Centre Experience 118
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 117
New onset of Susac syndrome after mRNA COVID-19 vaccine: a case report 116
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 116
Clinical features and outcome of patients with autoimmune cerebellar ataxia evaluated with the Scale for the Assessment and Rating of Ataxia 115
Early neurological deterioration in patients with minor stroke due to isolated M2 occlusion undergoing medical management: a retrospective multicenter study 114
A novel risk score predicting 30-day hospital re-admission of patients with acute stroke by machine learning model 113
Movement disorders following mechanical thrombectomy resulting in ischemic lesions of the basal ganglia: An emerging clinical entity 108
Remission of functional motor symptoms following esketamine administration in a patient with treatmentresistant depression: A single-case report 107
A proof-of-concept study on CGRP plasma levels of migraineurs during a 6-month treatment with ERENUMAB 106
F057 Affective and cognitive components of theory of mind in Huntington’s disease: yoni task performance in early and mid-disease stages 105
Defining the disease course of TNFα blockers-associated Multiple Sclerosis 105
A multiple hits hypothesis for memory dysfunction in Parkinson disease 103
Performance of Fully-Automated High-Throughput Plasma Biomarker Assays for Alzheimer’s Disease in Amnestic Mild Cognitive Impairment Subjects 101
Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington's disease 101
Baseline clinical and neuroradiological predictors of outcome in patients with large ischemic core undergoing mechanical thrombectomy: a retrospective multicenter study 101
Alpha-synuclein in Parkinson's disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction 99
Effects of deep brain stimulation of the subthalamic nucleus on patients with Parkinson's disease: a machine-learning voice analysis 99
Cortical plasticity after hand prostheses use: Is the hypothesis of deafferented cortex “invasion” always true? 99
Unprotected stroke management in an undiagnosed case of Severe Acute Respiratory Syndrome Coronavirus 2 infection 98
Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit 98
Autonomic dysfunction in non-critically ill COVID-19 patients during the acute phase of disease: an observational, cross-sectional study 97
Association of Obstructive Sleep Apnea and Atrial Fibrillation in Acute Ischemic Stroke: A Cross-Sectional Study 96
A novel stroke mimic prediction score during in-hospital triage for suspected stroke patients: The Stroke Mimics Score (SMS) 96
Erratum: Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis (Scientific Reports (2016) 6 (20926) DOI: 10.1038/srep20926) 96
Ixekizumab exposure associated with myelitis: A case report and a literature review 95
Automated pupillometry is a predictor of outcome of stroke patients: An observational, prospective, cohort study 93
Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's disease. 93
Clinical and genetic characteristics of late-onset Huntington's disease in a large European cohort 93
Effect of the COVID-19 pandemic and the lockdown measures on the local stroke network 92
The Italian version of Cognitive Function Instrument (CFI) for tracking changes in healthy elderly: results at 1-year follow-up 92
Theory of Mind in migraine and medication-overuse headache: A cross-sectional study 91
Developmental impaired Akt signaling in the Shank1 and Shank3 double knock-out mice 91
COVID-19 Pandemic and Psychiatric Symptoms: The Impact on Parkinson's Disease in the Elderly 90
Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts 90
Transcranial Magnetic Stimulation Exerts “Rejuvenation” Effects on Corticostriatal Synapses after Partial Dopamine Depletion 90
Migraine-specific quality of life questionnaire and relapse of medication overuse headache 89
Long-term shaping of corticostriatal synaptic activity by acute fasting 88
Personalized clinical phenotyping through systems medicine and artificial intelligence 88
CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple Sclerosis 87
COVID-19 Vaccination Is Associated with a Better Outcome in Acute Ischemic Stroke Patients: A Retrospective Observational Study 86
Neuroplasticity in levodopa-induced dyskinesias: An overview on pathophysiology and therapeutic targets 86
Alpha-Synuclein Produces Early Behavioral Alterations via Striatal Cholinergic Synaptic Dysfunction by Interacting With GluN2D N-Methyl-D-Aspartate Receptor Subunit 86
Antiseizure medications for the prophylaxis of migraine during the anti-CGRP drugs era 85
Clinical and genetic characteristics of late-onset Huntington's disease in a large European cohort 85
Theory of Mind in migraine and medication-overuse headache: A cross-sectional study 84
Neurofilament light chain as a biomarker in neurological disorders 84
Intensive exercise ameliorates motor and cognitive symptoms in experimental Parkinson's disease restoring striatal synaptic plasticity 84
Artificial intelligence to predict individualized outcome of acute ischemic stroke patients: The SIBILLA project 83
Automated Pupillometry Is Able to Discriminate Patients with Acute Stroke from Healthy Subjects: An Observational, Cross-Sectional Study 82
Associations Between Free and Cued Selective Reminding Test and Cerebrospinal Fluid Biomarkers in Amnestic Mild Cognitive Impairment 82
An evolving redefinition of autoimmune encephalitis 82
Advances in understanding of the function of alpha-synuclein: implications for Parkinson's disease 81
Evidence of Hydrogen Sulfide Involvement in Amyotrophic Lateral Sclerosis 81
Dopamine-dependent long-term depression is expressed in striatal spiny neurons of both direct and indirect pathways: implications for Parkinson's disease 81
Basal ganglia ischaemic infarction after thrombectomy: cognitive impairment at acute stage 80
Actigraphic Sensors Describe Stroke Severity in the Acute Phase: Implementing Multi-Parametric Monitoring in Stroke Unit 80
Temporalis muscle thickness as a predictor of functional outcome after reperfusion therapies for acute ischemic stroke: a retrospective, cohort study 80
Dopamine drives binge-like consumption of a palatable food in experimental Parkinsonism 80
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 80
Theory of mind: A clue for the interpretation of functional movement disorders 79
Efficacy and safety of long-term botulinum toxin treatment for acquired cervical dystonia: a 25-year follow-up 79
Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis 78
Stroke integrated care pathway during COVID-19 pandemic 78
Effects of uremic toxins on hippocampal synaptic transmission: implication for neurodegeneration in chronic kidney disease 78
Differential profiles of serum cytokines in Parkinson's disease according to disease duration 77
Long-Term Headache Outcome and Radiological Correlates in Patients With Intracranial Hypotension 77
Low doses of Perampanel protect striatal and hippocampal neurons against in vitro ischemia by reversing the ischemia-induced alteration of AMPA receptor subunit composition 77
Instrumental Evaluation of COVID-19 Related Dysautonomia in Non-Critically-Ill Patients: An Observational, Cross-Sectional Study 76
Effects of central and peripheral inflammation on hippocampal synaptic plasticity 76
A positive allosteric modulator of mGlu4 receptors restores striatal plasticity in an animal model of l-Dopa-induced dyskinesia 76
Predictors of parenchymal hematoma and clinical outcome after mechanical thrombectomy in patients with large ischemic core due to large vessel occlusion: a retrospective multicenter study 75
Correction to: Preventive migraine treatment in mitochondrial diseases: a case report of erenumab efficacy and literature review 75
Autonomic Dysfunction during Acute SARS-CoV-2 Infection: A Systematic Review 74
Treatment of benzodiazepine-refractory status epilepticus: A retrospective, cohort study 74
Long-term safety and efficacy of frameless subthalamic deep brain stimulation in Parkinson's disease 74
Basal ganglia ischaemic infarction after thrombectomy: cognitive impairment at acute stage 74
Clinical and genetic characteristics of late-onset Huntington's disease in a large European cohort 74
Mechanical thrombectomy in patients with stroke due to large vessel occlusion in the anterior circulation and low baseline NIHSS score 74
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 74
Social cognition in basal ganglia pathologies: Theory of Mind in Huntington's and Parkinson's diseases 73
Cerebral edema in acute stroke: Effect of thrombolytic treatment 73
Totale 10.377
Categoria #
all - tutte 106.740
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.740


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021357 0 0 0 0 0 20 66 12 140 44 59 16
2021/20221.081 91 28 35 114 31 27 25 187 54 59 208 222
2022/20232.114 289 204 174 232 99 229 100 146 328 98 174 41
2023/20242.076 47 481 77 117 98 257 159 114 64 79 258 325
2024/20255.792 91 105 362 154 233 265 410 263 863 518 1.336 1.192
2025/20268.113 2.015 498 1.232 1.772 2.039 557 0 0 0 0 0 0
Totale 19.955